CVS Health (NYSE:CVS) announced today that it plans to add more than 2,000 new COVID-19 drive-thru test sites at select locations around the U.S.
Currently, CVS manages the largest number of independently run COVID-19 test sites in the country, according to a news release. It expects that the 2,000 new locations will just about double its total testing sites, tallying more than 4,000 in operation by mid-October.
Over the next several weeks, the new locations will open in waves across the testing locations in 33 states and Washington, D.C., starting with the opening of more than 400 new sites tomorrow. A complete list of CVS Pharmacy drive-thru test sites can be found here.
Self-swab tests at CVS are offered at no cost to patients and available to anyone meeting CDC criteria following online registration through CVS’ website. Upon arrival, patients must follow signage or onsite staff instruction as procedures vary from location to location. Patients will be provided with a test kit and given instructions while a CVS Pharmacy team member observes the process.
CVS said, as of now, most test results from specimens collected at its testing sites will be available within two to three days.
“Since opening our first test site in March, we’ve been able to quickly adapt to the changing landscape in order to make it easier for people in the communities we serve to access testing,” CVS Health COO & CVS Pharmacy acting presdient Jon Roberts said in the release. “We recognize the critical role testing plays in helping to manage the spread of the virus and are incredibly proud of how our teams have responded to this need while continuing to take care of our customers, clients and patients.”